Gabapentin is effective in treating nocturnal painful spasms in multiple sclerosis

Abstract

In-patients with MS nocturnal spasms (NPS) occur frequently, primarily during the night and may influence the ability to and/or quality of sleep. We enrolled in an open label trial with GBP (up to 600 mg/day) 24 MS patients with NPS. We obtained patient reports of subjective discomfort at pre-treatment and following 2- (T1) and 8 weeks (T2), utilizing a 3-point analogue scale. Twenty of the 22 patients who completed the study reported resolution or amelioration of discomfort. Clinical improvement occurred 1-5 days following initial treatment. Three patients experienced adverse effects but completed the minimal follow-up period (2 weeks). Two patient dropped out of the study due to no compliance or adverse effects. A very low dose of GBP may be effective treatment for MS patients with NPS who may benefit from rapid improvement of discomfort with minimal risk of adverse effects.

Keywords

Multiple sclerosis gabapentin nocturnal painful spasms

Get full access to this article

View all access options for this article.

References

Schapiro RT , Baumhefner RW , Tourtellotte WW. (1997) Multiple sclerosis: a clinical viewpoint to management. In: Raine CS, McFarland HF, Tourtellotte WW. Multiple sclerosis: Clinical and pathogenetic basis. London: Chapman & Hall pp. 391-420.

Chadwick D. (1994) Gabapentin . Lancet 343: 89-91 .

Mueller ME , Gruenthal M , Olson WL , Olson WH. (1997) Gabapentin for relief of upper motor neuron symptoms in multiple sclerosis . Arch Phys Med Rehabil 78: 521-524 .

Dunevsky A , Perel AB. (1998) Gabapentin for relief of spasticity associated with Multiple Sclerosis . Am J Phys Med Rehabil 77: 451-454 .

Houtchens MK. (1997) Open label gabapentin treatment for pain in multiple sclerosis . Multiple Sclerosis 3: 250-253 .

Samkoff LM , Daras M , Tuchman AJ , Koppel BS. (1997) Amelioration of refractory dysesthetic limb pain in multiple sclerosis by gabapentin . Neurology 49: 304-305 .

Solaro C et al. (1998) An open label trial of gabapentin treatment of paroxysmal symptoms in multiple sclerosis patients . Neurology 51: 609-611 .

Taylor CP. (1998) A summary the mechanistic hypotheses of gabapentin pharmacology . Epilepsy Res 29: 233-249 .